Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.
about
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype.Invasive Growth Hormone Producing Pituitary Adenoma With Lymphocytic Infiltration: A Case Report and Literature Review.Clinically silent somatotroph adenomas are common.Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas.Growth hormone tumor histological subtypes predict response to surgical and medical therapy.Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumorsClinicopathological Features of Growth Hormone-Producing Pituitary Adenomas in 242 Acromegaly Patients: Classification according to Hormone Production and Cytokeratin Distribution.Growth hormone is a cellular senescence target in pituitary and nonpituitary cellsClinical implications of growth hormone-secreting tumor subtypes.Clinicopathological correlations in pituitary adenomas.Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience.Familial isolated pituitary adenomas: an emerging clinical entity.Aggressive tumors and difficult choices in acromegaly.An analysis of granulation patterns, MIB-1 proliferation indices and p53 expression in 101 patients with acromegaly.Progress in the Diagnosis and Classification of Pituitary Adenomas.Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes.Clinical Impact of the Current WHO Classification of Pituitary Adenomas.Management of aggressive growth hormone secreting pituitary adenomas.Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary.Overview of the 2017 WHO Classification of Pituitary Tumors.Epithelial and organ-related marker expression in pituitary adenomas.Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegalyThe 2017 World Health Organization classification of tumors of the pituitary gland: a summary.MGMT immunoexpression in growth hormone-secreting pituitary adenomas and its correlation with Ki-67 labeling index and cytokeratin distribution pattern.A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up.Histopathological classification of non-functioning pituitary neuroendocrine tumors.Elucidating the Role of the Desmosome Protein p53 Apoptosis Effector Related to PMP-22 in Growth Hormone Tumors.Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas.Oncogene-Induced Senescence in Pituitary Adenomas--an Immunohistochemical Study.Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas.Failure of temozolomide and conventional doses of pegvisomant to attain biochemical control in a severe case of acromegalyAdenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegalyNew directions in pharmacological treatment of acromegaly
P2860
Q30276702-0EE40998-C0AF-44AC-BBBA-BC2B15D549E4Q30458346-F7B6AA1D-C2AC-491E-99F2-B31257F1B7F1Q31043574-7C25B19E-8355-4DCF-9435-7C95A61DC17DQ35055146-78A3FC80-F13F-4DD4-8B34-52C9885EA172Q35057730-A3DE0DB0-6F9D-408E-A853-47DDB2CC1FA7Q35091578-EE834E38-F19D-4D51-A600-8673289BC891Q36270932-7FD6A9C8-832D-4639-A144-A41148FF6B8DQ36584412-4D54BB8E-82DD-490A-BF33-D1A482EDCFA6Q37143459-0CF88073-665D-42D4-A730-6A7F232D8650Q37995533-FAB827F9-EBF2-4B0B-A7DB-DCA1481BECF8Q38018648-C215F44D-8329-4B59-ADB4-AB075BBC108AQ38062852-DE834827-7E2F-49E2-A086-AAE4FE55296BQ38073256-50D7BE17-EAB0-4C8D-BBC5-3D27102F6B45Q38167711-4E4AB389-0A94-4AA6-8C23-5314363BD0A6Q38252677-E252A8A4-005D-48D5-9B30-F4E91FB3811CQ38540507-AD8AECFE-A71D-447E-9311-3293C2E52F72Q38604420-3CF92747-FD5D-41A5-999F-90164C950706Q38727622-1E780AB8-2BF3-4709-9083-C05AF6E71573Q38781620-4F5D18D8-798D-4E55-9D05-C2FCD20786B5Q38944306-882C2DF6-AE82-4D61-B5A1-2145E6BCBA3FQ39190559-C58E0426-898D-40A3-9240-736372363B6AQ39908599-33C6E97F-0B86-4ED5-8BCE-56D55F7FB28DQ40131008-D0D3794F-2982-4618-A0A3-A9A531B75745Q41014890-9FEBF935-FE54-4921-A956-ECD86F9D1F69Q45065674-4E615EC3-D2FA-41B9-8F16-8381DB88B82EQ45761917-3A701840-A770-47BA-92AD-677EFC8AFFFBQ46411571-E4825E3E-DA01-45BB-BDC2-CD67E548E07AQ47252651-8B666997-5846-4DB5-9970-530E38B6EE32Q47939983-27A59FB9-2D36-40B6-AA52-84504B941DBBQ52151895-8452E5FC-2B7F-4654-AD84-F87477E8187EQ53275836-42178A61-CA60-40B9-906A-E19C69627DA9Q55074584-668DE8D3-719B-4BCC-A02E-6E6E11CCC215Q56964443-8D0CBE43-8BFE-482A-A394-419F8BF56CEBQ58897830-042E7F40-FFA2-482A-ADAD-07E612577671Q58897890-9ECC576F-848B-4C8A-9475-5FD1157B17E7
P2860
Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Clinicopathological features o ...... including a transitional form.
@ast
Clinicopathological features o ...... including a transitional form.
@en
type
label
Clinicopathological features o ...... including a transitional form.
@ast
Clinicopathological features o ...... including a transitional form.
@en
prefLabel
Clinicopathological features o ...... including a transitional form.
@ast
Clinicopathological features o ...... including a transitional form.
@en
P2093
P1433
P1476
Clinicopathological features o ...... including a transitional form.
@en
P2093
Abdulkader Obari
Akiko Yoneda
Kenichi Ohyama
Muhammad Mustafizur Rahman
Nasim Rayhan
Shozo Yamada
Toshiaki Sano
P2888
P356
10.1007/S12022-008-9029-Z
P577
2008-01-01T00:00:00Z
P5875
P6179
1014243387